MEC Plus – MyMedflix Member Portal

Skip to content

Live Events

Live Events

Live Events

Live Events

MEC Plus

Events

Speciality

Type of Media

Author / Speaker

Title

Search Entries:

«
1
…
62
63
64
65
66
…
100
»

Role of Interventional Radiology in Oncology Care

Role of Interventional Radiology in Oncology Care

Brian F Baigorri, MD, RPVI

Biosimilars Implementation in the United States: Where Opportunities Remain

Biosimilars Implementation in the United States: Where Opportunities Remain

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE

Advances in the Treatment of CNS Malignancies

Advances in the Treatment of CNS Malignancies

Frances Chow, MD

SCLC Case

Marie Suga, MD, MPH

Stage IV KRAS Mutant Lung Cancer Case

Stage IV KRAS Mutant Lung Cancer Case

Jonathan W. Riess, MD, MS

EGFR-Mutated Lung Cancers

EGFR-Mutated Lung Cancers

Collin Blakely, MD, PhD

Immunotherapy

David R. Gandara, MD.

Follicular Lymphoma: Novel Advances and Pathways

Follicular Lymphoma: Novel Advances and Pathways

Nahkle Saba, MD

DLBCL & Hodgkin’s Disease: Novel Approaches

DLBCL & Hodgkin’s Disease: Novel Approaches

Eduardo Sotomayor, MD

T-Cell NHL: What’s New?

T-Cell NHL: What’s New?

Francine M. Foss, MD

Anticoagulation in the Oncology Patient

Anticoagulation in the Oncology Patient

Pamela Dudkiewicz, ARPN

CLL: Novel Therapies

CLL: Novel Therapies

Javier Pinilla-Ibarz, MD

Myeloma, So Many Therapeutic Options in the Relapse Setting: How to Sequence Them?

Myeloma, So Many Therapeutic Options in the Relapse Setting: How to Sequence Them?

Jonathan Kaufman, MD

Myelodysplasia: Biomarkers, Risk Assessment and Novel Treatments

Myelodysplasia: Biomarkers, Risk Assessment and Novel Treatments

Rami Komrokji, MD

Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges

Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges

Mohamed Kharfan-Dabaja, MD

De Novo Acute Myeloid Leukemia

De Novo Acute Myeloid Leukemia

Hugo Fernandez, MD

New Agents and New Toxicities in Malignant Hematology: BCL2 Inhibitors, Anti-BCMA, and FLT3 Inhibitors

New Agents and New Toxicities in Malignant Hematology: BCL2 Inhibitors, Anti-BCMA, and FLT3 Inhibitors

Nicole Ianniello, PharmD

RET, MET & B-RAF mutations in NSCLC

RET, MET & B-RAF mutations in NSCLC

Janakiraman Subramanian, MD, MPH

ERBB2 and NGR1 Pathways in NSCLC

ERBB2 and NGR1 Pathways in NSCLC

Estelamari Rodriguez, MD

ALK, ROS1 & NTRK Mutations in NSCLC

ALK, ROS1 & NTRK Mutations in NSCLC

Corey Langer, MD

EGFR and K-RAS Mutations in NSCLC

EGFR and K-RAS Mutations in NSCLC

Edgardo S. Santos Castillero, MD

Lung Cancer Clinical Scenarios: How Liquid Biopsy Technology Is Delivering Personalized Therapy in NSCLC

Lung Cancer Clinical Scenarios: How Liquid Biopsy Technology Is Delivering Personalized Therapy in NSCLC

Christian Rolfo, MD

Adjuvant and Neoadjuvant Novel Concepts and Strategies in NSCLC

Adjuvant and Neoadjuvant Novel Concepts and Strategies in NSCLC

David Gandara, MD

Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?

Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?

Paul Bunn, MD

Integrative Oncology in Cancer Care

Integrative Oncology in Cancer Care

Ashwin Mehta, MD

Thyroid Cancer & Thymic Carcinoma: Recent Advances

Thyroid Cancer & Thymic Carcinoma: Recent Advances

Raja Mudad, MD

Metastatic Cancer Survivorship Care

Metastatic Cancer Survivorship Care

Adrienne M. Vazquez Guerra, MSN, ACNP-BC, AOCN

Neuroendocrine Tumors (NET): Novel Advances in Therapy

Neuroendocrine Tumors (NET): Novel Advances in Therapy

Pasquale W. Benedetto, MD

Castration Resistant Prostate Cancer (CRPC), Non-Metastatic & Metastatic: Novel Therapeutic Advances

Castration Resistant Prostate Cancer (CRPC), Non-Metastatic & Metastatic: Novel Therapeutic Advances

Michael Hurwitz, MD, PhD

Immunotherapy in Metastatic Breast Cancer

Immunotherapy in Metastatic Breast Cancer

Alberto Montero, MD

Displaying 1,891 - 1,920 of 2,995

«
1
…
62
63
64
65
66
…
100
»

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok